Top Markets
#1 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +18.38%
#2 Victoria VR Victoria VR +9.12%
#3 Movement Movement +8.40%
#4 DMT-NAT DMT-NAT +6.93%
#5 Palladium Network Palladium Network +4.63%
#6 Prom Prom +4.55%
#7 Pons Pons +4.23%
#8 GRVT Token GRVT Token +3.85%
#9 Cryptopia Cryptopia +3.74%
#10 COTI COTI +3.65%
Coin of the day
FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock)
Ustawienia
Język
POLSKI
Waluta
USD
Motyw
Arch Therapeutics, Inc. Arch Therapeutics, Inc.

Arch Therapeutics, Inc.

ARTH
Pozycja w akcjach #42478
Arch Therapeutics, Inc., operating alongside its affiliated companies,... Arch Therapeutics, Inc., operating alongside its affiliated companies, functions as a biotechnology firm within the United States. The organization focuses on developing and commercializing products derived from its unique AC5 self-assembling technology platform. These innovations are engineered to arrest bleeding, control fluid leakage, and assist in wound care during surgical interventions, following trauma, throughout interventional medical procedures, or in cases of disease. Its leading products, the AC5 advanced wound system and the AC5 topical hemostat, are specifically designed for application on the skin, proving effective for managing intricate chronic wounds or acute surgical injuries. The company was established in 2006 and is headquartered in Framingham, Massachusetts.
Cena akcji
$0.0009
Ostatnia synchronizacja: 2025-05-27
Kapitalizacja rynkowa
$1.15K
Zmiana (1 dzień)
0.00%
Zmiana (1 rok)
0.00%
Kraj
US
Handel Arch Therapeutics, Inc. (ARTH)

Kategoria

Healthcare
Historia ceny akcji dla Arch Therapeutics, Inc. (ARTH)
Najwyższa cena zamknięcia: $0.00 dnia 2025-05-01

Najniższa cena zamknięcia: $3.67K dnia 2012-12-01
Historia cen akcji firmy Arch Therapeutics, Inc. od 2012 do 2026
Roczna wydajność ceny akcji
Rok Wydajność
2025 -99.61%
2024 -97.03%
2023 -5.00%
2022 -64.68%
2021 -28.45%
2020 -99.69%
2019 -51.23%
2018 -17.82%
2017 1.40%
2016 175.64%
2015 5.30%
2014 -2.69%
2013 131.37%
2012 0.00%
Cena akcji podobnych firm lub konkurencji
Firma Cena akcji Zmiana 1r% Kraj
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $527.87 33.33%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $873.57 35.10%
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 $736.38 7.69%
CH
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
 $263.09 18.09%
BE
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
 $1.08K -6.44%
KR